Our approach

Because discovery is just the beginning.

Scout & Validate

We identify promising academic science and assess technical and commercial viability

We leverage and co-develop product strategy and ensure strong IP positioning

We guide development, trials, and partner engagement for market readiness.

Shape & Protect

Build & Launch

About us

We are a mission-driven venture builder with deep scientific, clinical, and regulatory expertise across the biotech landscape. With over two decades of global experience in drug and medical device development—spanning 110+ clinical programs across Europe, the U.S., Latin America, and Asia—we understand what it takes to turn early-stage science into market-ready solutions.

Our leadership has worked at the intersection of clinical strategy, regulatory navigation, and product launch, helping companies—from startups to global pharma—maximize the value of their innovations. At Atlantica, we bring this same level of strategic clarity and executional rigor to academic teams and founders building the next generation of health technologies.

How we power health innovation

We offer customized strategies aligned with the specific needs of each biotech venture.

Regulatory Strategy & Development Planning

• Identification of regulatory and R&D pathways for each stage of development.

• Design of complete technical-regulatory roadmaps, including preclinical and clinical plans.

• Strategic and technical support during interactions with partners and regulatory agencies.

Intellectual Property & Valuation

• Strategic support in patent drafting, review, and submission.

• Development of robust patent valuation studies.

• Support in building a strategic IP narrative that maximizes asset value for partners and investors

Business Strategy & Partnering

• Business model structuring and refinement.

• Identification and activation of strategic partners.

• Support on contracts and negotiation for commercial partnerships or co-development.

• Development of scientific, strategic and regulatory narratives that position the product competitively.

• Support in the preparation and submission of academic or commercial funding proposals.

Research and development

• Guidance on product development requirements.

• Planning, management and oversight of non-clinical studies with high-quality, cost-effective structure.

• Planning of early-phase clinical trials focused on safety, exploratory efficacy, and investor appeal.

The Future We’re Co-Creating

Behind every project we support is a shared vision: to deliver smarter, faster, and more inclusive healthcare solutions to the world.

Breast cancer screening

A breakthrough blood test designed for early breast cancer screening in women. Rosalind detects cancer-associated biomarkers before symptoms arise, enabling earlier intervention and improved outcomes.

CAR-Macrofage for solid tumors

A novel cell therapy using engineered macrophages to overcome the limits of CAR-T in solid tumors. By reprogramming the innate immune system, it offers a new path to durable responses in resistant cancers.

Plant-based medicines

We’re advancing the development of plant-based therapies for individuals facing several health conditions, from gastrointestinal intolerance to substance abuse.
Novel approaches targeting diferent biological roots offering new hope for patients.

Cancer Detection Platform

A non-invasive, blood-based platform for the early detection of multiple cancer types. Z-Can uses advanced molecular profiling to identify early-stage disease—bringing precision oncology closer to everyday practice.

Canine Breast Cancer Test

An innovative diagnostic developed to detect breast cancer in dogs with high sensitivity.
This test opens new frontiers in veterinary oncology, supporting early diagnosis and targeted treatment in companion animals.

Tech-enhanced diagnostics

A smart data platform that aggregates and analyzes biomarker information across diverse sources—genetic, proteomic, molecular—to support faster, more precise, and context-aware diagnosis. It gives clinicians and researchers a unified view of disease signals to improve accuracy and enable earlier, more targeted care.

We collaborate with academic scientists, biotech startups, and health innovators to turn promising science into high-impact ventures. Whether you're developing a novel diagnostic, therapeutic, or platform technology, we bring strategic guidance, technical depth, and a clear path to market.

From shaping IP and product strategy to coordinating studies and driving co-development deals, we work side by side with you—maximizing value every step of the way.

★★★★★

Be part of the next wave of innovation